| Literature DB >> 26589897 |
Søren Glud Skousgaard1,2,3, Jacob Hjelmborg4, Axel Skytthe5, Lars Peter Andreas Brandt6,7, Sören Möller8, Søren Overgaard9,10.
Abstract
INTRODUCTION: Primary hip osteoarthritis, radiographic as well as symptomatic, is highly associated with increasing age in both genders. However, little is known about the mechanisms behind this, in particular if this increase is caused by genetic factors. This study examined the risk and heritability of primary osteoarthritis of the hip leading to a total hip arthroplasty, and if this heritability increased with increasing age.Entities:
Mesh:
Year: 2015 PMID: 26589897 PMCID: PMC4654897 DOI: 10.1186/s13075-015-0854-4
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Fig. 1Flow chart of the participating twins. DHR Dansih Hip Arthroplasty Register, DTR Danish Twin Register, OA Osteoarthritis, THA Total hip arthroplasty
Distribution by zygosity, sex, THA and vital status
| THA by zygosity | Distribution by sex | Distribution by vital status | ||||||
|---|---|---|---|---|---|---|---|---|
| Zygosity | Males (n) | Females (n) (%) | Total by sex (n) | Males alive (n) | Males dead (n) | Females alive (n) | Females dead (n) | Total by vital status (n) |
| MZ + THA | 88 | 90 (51) | 178 | 71 | 17 | 72 | 18 | 178 |
| MZ – THA | 9861 | 10,288 (51) | 20,149 | 8671 | 1190 | 9059 | 1229 | 20,149 |
| DZ + THA | 184 | 189 (51) | 373 | 141 | 43 | 155 | 34 | 373 |
| DZ – THA | 18,015 | 16,975 (49) | 34,990 | 15,417 | 2598 | 14,486 | 2489 | 34,990 |
| OS + THA | 135 | 149 (52) | 284 | 120 | 16 | 136 | 12 | 284 |
| OS – THA | 19,005 | 19,084 (50) | 38,089 | 17,491 | 1514 | 17,892 | 1192 | 38,089 |
| Total | 47,288 | 46,775 (50) | 94,063 | 41,911 | 5378 | 41,799 | 4974 | 94,063 |
DZ same-sex dizygotic, MZ monozygotic, OS opposite-sex dizygotic, + THA Total hip arthroplasty, – THA No hip arthroplasty
Concordance and tetrachoric correlations
| Zygosity | Concordant pairs with THA due to OA n (%) | Discordant pairs with THA due to OA n (%) | Concordant pairs without THA n (%) | Total twin pairs in zygosity groups n (%) | Tertrachoric correlations |
|---|---|---|---|---|---|
| MZM | 10 (0.2) | 57 (1.2) | 4558 (98.6) | 4625 (100) | 0.70 |
| DZM | 5 (0.1) | 148 (1.8) | 8107 (98.1) | 8260 (100) | 0.33 |
| MZF | 9 (0.2) | 72 (1.5) | 4773 (98.3) | 4855 (100) | 0.66 |
| DZF | 5 (0.1) | 148 (1.9) | 7740 (98.0) | 7893 (100) | 0.33 |
| OSDZ | 7 (0.05) | 223 (1.25) | 17,602 (98.7) | 17,832 (100) | 0.41 |
DZF dizygotic females, DZM dizygotic males, MZF monozygotic females, MZM monozygotic males, OA Osteoarthritis, OSDZ opposite-sex dizygotic twin pairs, THA Total hip arthroplasty
Fig. 2Cumulative incidence. Cumulative incidence for THA in males (red line) and females (black line)
Fig. 3Proband-wise concordance rate by age in THA, sex-adjusted. DZ Dizygotic, Marginal Background incidence, MZ Monozygotic
Prevalences, tetrachorics, case-wise concordance rates, heritability, biometric models and chi-squared test statistics
| Model | MZ prevalence | DZ prevalence | MZr | DZr | MZcw | DZcw | Heritability | Variance component estimates | Chisquare test statistics | AIC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | D | C | E | LL | Chisquare | df |
| |||||||||
| Men | ||||||||||||||||
| Saturated | 0.06 | 0.06 | 0.80 (0.57–0.91) | 0.41 (0.09–0.65) | 0.51 (0.33–0.70) | 0.21 (0.10–0.40) | 0.78 (0.07–0.99) | – | – | – | – | –621.44 | 6 | 1254.88 | ||
| ACE | 0.06 | 0.06 | 0.80 (0.57–0.91) | 0.41 (0.09–0.65) | 0.51 (0.33–0.70) | 0.21 (0.10–0.40) | 0.78 (0.07–0.99) | 0.78 (0.07–0.99) | – | 0.02 (0.00–1.0) | 0.20 (0.08–0.41) | –621.44 | 6 | 1254.88 | ||
| ADE | 0.06 | 0.06 | 0.80 (0.58–0.91) | 0.40 (0.32–0.47) | 0.51 (0.34–0.69) | 0.21 (0.16–0.26) | 0.80 (0.60–0.91) | 0.80 (0.60–0.91) | 0.00 (0.00–1.00) | – | 0.20 (0.09–0.40) | 1255.30 | ||||
| AE | 0.06 | 0.06 | 0.80 (0.58–0.91) | 0.40 (0.32–0.47) | 0.51 (0.34–0.69) | 0.21 (0.16–0.26) | 0.80 (0.60–0.91) | 0.80 (0.60–0.91) | – | – | 0.20 (0.09–0.40) | –621.65 | 0.42 | 2 | 0.81 | |
| CE | 0.07 | 0.07 | 0.63 (0.44–0.76) | 0.63 (0.44–0.76) | 0.37 (0.26–0.50) | 0.37 (0.26–0.50) | – | – | – | 0.63 (0.46–0.77) | 0.37 (0.23–0.54) | –2921.4 | 4600 | 2 | <0.0001 | |
| Women | ||||||||||||||||
| Saturated | 0.06 | 0.06 | 0.72 (047–0.87) | 0.46 (0.15–0.69) | 0.42 (0.25–0.61) | 0.23 (0.11–0.43) | 0.52 (0.07–0.94) | – | – | – | – | –621.44 | 6 | 1254.88 | ||
| ACE | 0.06 | 0.06 | 0.72 (0.47–0.87) | 0.46 (0.15–0.69) | 0.42 (0.25–0.61) | 0.23 (0.11–0.43) | 0.52 (0.07–0.94) | 0.52 (0.07–0.94) | – | 0.20 (0.006–0.91 | 0.28 (0.13–0.50) | –621.44 | 6 | 1254.88 | ||
| ADE | 0.06 | 0.06 | 0.74 (0.52–0.87) | 0.37 (0.28–0.45) | 0.44 (0.28–0.61) | 0.18 (0.14–0.24) | 0.74 (0.54–0.87) | 0.74 (0.54–0.87) | 0.00 (0.00–1.00) | 0.26 (0.13–0.46) | 1255.30 | |||||
| AE | 0.06 | 0.06 | 0.74 (0.52–0.87) | 0.37 (0.28–0.45) | 0.44 (0.28–0.61) | 0.18 (0.14–0.24) | 0.74 (0.54–0.87) | 0.74 (0.54–0.87) | – | – | 0.26 (0.13–0.46) | –621.65 | 0.42 | 6 | 0.81 | |
| CE | 0.07 | 0.07 | 0.66 (0.48–0.79) | 0.66 (0.48–0.79) | 0.37 (0.26–0.50) | 0.37 (0.26–0.50) | – | – | – | 0.66 (0.50–0.79) | 0.34 (0.21–0.50) | –2921.4 | 4600 | 2 | <0.0001 | |
| Sex-adjusted | ||||||||||||||||
| Saturated | 0.06 | 0.06 | 0.68 (0.55–078) | 0.45 (0.23–0.62) | 0.39 (0.30–0.50) | 0.23 (0.14–0.36) | 0.47 (0.12–0.85) | – | – | – | – | –806.7 | 2 | 1621.34 | ||
| ACE | 0.06 | 0.06 | 0.68 (0.55–0.78) | 0.45 (0.23–0.62) | 0.39 (0.30–0.50) | 0.23 (0.14–0.36) | 0.47 (0.12–0.85) | 0.47 (0.12–0.85) | – | 0.22 (0.02–0.76) | 0.31 (0.21–0.44) | –806.7 | – | 4 | 1621.34 | |
| ADE | 0.06 | 0.06 | 0.70 (0.57–0.80) | 0.35 (0.29–0.40) | 0.41 (0.31–0.51) | 0.18 (0.15–0.21) | 0.70 (0.58–0.79) | 0.70 (0.58–0.80) | 0.00 (0.00–0.00) | – | 0.30 (0.21–0.42) | 1622.31 | ||||
| AE | 0.06 | 0.06 | 0.70 (0.58–0.79) | 0.35 (0.29–0.40) | 0.41 (0.31–0.51) | 0.18 (0.15–0.21) | 0.70 (0.58–0.79) | 0.70 (0.58–0.79) | – | – | 0.30 (0.21–0.42) | –807.2 | 0.97 | 1 | 0.325 | |
| CE | 0.07 | 0.07 | 0.62 (0.51–0.71) | 0.62 (0.51–0.71) | 0.37 (0.29–0.45) | 0.37 (0.29–0.45) | – | – | – | 0.62 (0.52–0.72) | 0.38 (0.28–0.48) | –2913.8 | 4214 | 1 | <0.0001 | |
A Additive genetic, AIC Akaiki’s information criterion, C Common environment, D Dominant genetic, DZcw Dizygotic case-wise concordance rate, DZr Dizygotic correlation, E Unique environment, MZcw Monozygotic case-wise concordance rate, MZr Monozygotic correlation, Saturated Saturated model not including censoring
Fig. 4Heritability of THA by age additive genetic factors only. Sex-adjusted variation in liability to THA from additive genetic factors by age. CI Confidence interval
Fig. 5Heritability of THA by age, including the ACE model. Sex-adjusted variation in liability to THA from additive genetic (red line), common (blue line) and unique (green line) environmental factors by age. CI Confidence interval